Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy

INTRODUCTION: SARS-CoV-2 vaccines’ effectiveness is not yet clearly known in immunocompromised patients. This study aims to assess the humoral and cellular specific immune response to SARS-CoV-2 vaccines and the predictors of poor response in patients with common variable immunodeficiency (CVID) phe...

Descripción completa

Detalles Bibliográficos
Autores principales: Antolí, Arnau, Rocamora-Blanch, Gemma, Framil, Mario, Mas-Bosch, Virgínia, Navarro, Sergio, Bermudez, Carla, Martinez-Yelamos, Sergio, Dopico, Eva, Calatayud, Laura, Garcia-Muñoz, Nadia, Hernández-Benítez, Luis Humberto, Riera-Mestre, Antoni, Bas, Jordi, Masuet-Aumatell, Cristina, Rigo-Bonnin, Raúl, Morandeira, Francisco, Solanich, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098934/
https://www.ncbi.nlm.nih.gov/pubmed/35572562
http://dx.doi.org/10.3389/fimmu.2022.895209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098934/
https://www.ncbi.nlm.nih.gov/pubmed/35572562
http://dx.doi.org/10.3389/fimmu.2022.895209

Ejemplares similares